|1.||Fearon, Eric R: 5 articles (12/2008 - 03/2002)|
|2.||Shacham, Sharon: 4 articles (03/2014 - 11/2012)|
|3.||Cho, Kathleen R: 4 articles (12/2008 - 03/2002)|
|4.||Wu, Rong: 4 articles (12/2008 - 03/2002)|
|5.||McCauley, Dilara: 3 articles (03/2014 - 11/2012)|
|6.||Kauffman, Michael: 3 articles (07/2013 - 11/2012)|
|7.||Dinda, Sumi: 3 articles (12/2011 - 01/2002)|
|8.||Butel, Janet S: 3 articles (09/2003 - 01/2003)|
|9.||Vilchez, Regis A: 3 articles (09/2003 - 01/2003)|
|10.||Salla, Mohamed: 2 articles (10/2015 - 08/2014)|
07/01/2014 - "Overall, our studies suggest that an antibody-based therapy against sEcad may be a novel therapeutic platform for cutaneous SCCs by hampering key proto-oncogenes (RTKs, IAPs, and MDM2) and activating potent tumor suppressor proteins (PTEN and p53) intricately linked to tumor growth and survival."
10/02/2015 - "The loss of RASSF1A (an upstream regulator of MOAP-1) is one of the earliest detectable epigenetically silenced tumor suppressor proteins in cancer, and we speculate that the additional loss of function of MOAP-1 may be a second hit to functionally compromise the RASSF1A/MOAP-1 death receptor-dependent pathway and drive tumorigenesis. "
02/10/2015 - "Noticeably, the tumor suppressor proteins whose levels have been shown to be downregulated by SKP2-dependent degradation in various tumor types, including p27, p57, Dusp1, and Rassf1A were not decreased in liver lesions from SKP2/N-RasV12 and SKP2/myr-AKT1 mice. "
01/01/2015 - "As most of the other tumor suppressor proteins, TOB1 is inactivated in many human cancers. "
01/01/2015 - "Here we discuss different cancer related proteins (tumor suppressor genes, oncogenes, and enzymatic therapeutic targets), their function, and their association with CRM1, as well as agents that specifically inhibit CRM1, their mechanism of action, and their clinical relevance in certain human neoplasms. "
|2.||Retinoblastoma (Glioblastoma, Retinal)
05/01/2012 - "Array-based comparative genomic hybridization studies revealed deletions in the CDKN2A locus that include ARF and P16INK4A, both of which encode tumor suppressor proteins, in both human and mouse retinoblastoma. "
05/01/2015 - "E2Fs are negatively regulated by the retinoblastoma (RB) family of tumor suppressor proteins, and virus-encoded oncogenes disrupt the RB-E2F repressor complexes. "
12/01/2013 - "Its multiple roles are controlled by its interaction with several specific factors, including the tumor suppressor proteins BRCA1 and retinoblastoma. "
09/01/2005 - "The transforming activity of T Ag is due in large part to perturbation of the tumor suppressor proteins p53 and the retinoblastoma (pRB) family members. "
11/01/2004 - "The mammalian INK4a/ARF locus encodes two linked tumor suppressor proteins, p16INK4a and ARF, which respectively regulate the retinoblastoma (RB) and p53 pathways. "
|3.||Breast Neoplasms (Breast Cancer)
01/01/2013 - "Immunocytochemistry and western blot analysis were employed to study the colocalization and changes in MAPKs (ERK1/2 and p38), cell survival pathway (PI3K/AKT) and tumor suppressor proteins (PTEN and p53) in breast cancer cell lines. "
01/01/2008 - "GADD45A is an evolutionary conserved gene whose expression is regulated by two major tumor suppressor proteins involved in breast cancer etiology, namely, p53 and BRCA1, and which acts primarily in the control of the G2/M cell-cycle transition, apoptosis, and DNA repair. "
10/20/2004 - "These data, together with the identification of the PIBF gene in the chromosomal region associated with breast cancer susceptibility, reveal a strong parallel with known tumor suppressor proteins, such as BRCA1 and p53 having the same centrosomal localization. "
01/01/2001 - "Hormonal regulation of tumor suppressor proteins in breast cancer cells."
09/15/2005 - "Potential in vitro interaction of carboplatin with genes encoding tumor suppressor proteins such as human breast cancer suppressor gene 1(BRCA1) was herein investigated. "
|4.||Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/12/2005 - "In this study, we show that two tumor suppressor proteins, adenomatous polyposis coli (APC) and Dlg1-SAP97, are required for the polarization of migrating astrocytes. "
02/01/2006 - "Roughly 40% of ovarian endometrioid adenocarcinomas (OEA) have constitutive activation of Wnt signaling as a result of oncogenic mutations in the beta-catenin protein or inactivating mutations in key negative regulators of beta-catenin, such as the adenomatous polyposis coli and Axin tumor suppressor proteins. "
04/01/2002 - "In various cancers, inactivating mutations in the adenomatous polyposis coli or Axin tumor suppressor proteins or activating mutations in beta-catenin's amino-terminal domain elevate beta-catenin levels, resulting in marked effects on T-cell factor (TCF)-regulated transcription. "
10/01/1998 - "The tumor suppressor proteins neurofibromin (NF1) and adenomatous polyposis coli (APC) both bind to microtubules and interact with membrane-associated proteins. "
03/01/2002 - "In many cancers, inactivation of the adenomatous polyposis coli (APC) or Axin tumor suppressor proteins or activating mutations in beta-catenin lead to elevated beta-catenin levels, enhanced binding of beta-catenin to T cell factor (TCF) proteins, and increased expression of TCF-regulated genes. "
|5.||Melanoma (Melanoma, Malignant)
04/01/2009 - "Loss of tumor suppressor proteins, which function as brakes on cell growth, migration, or cell survival, was recognized early on as an important mechanism for initiation and progression of melanoma. "
07/01/2002 - "These results indicate that loss of function of these tumor suppressor proteins is a common occurrence that may contribute to the origin of canine melanoma. "
03/25/2004 - "In the spontaneous B16 melanoma cell lines, expression of p16Ink4a and p19Arf tumor suppressor proteins was lost as a consequence of a large deletion spanning Ink4a/Arf exons 1alpha, 1beta, and 2. In contrast, the carcinogen-induced melanoma cell lines expressed p16Ink4a but had inactivating mutations in either p19Arf (K1735) or p53 (CM519 and CM3205). "
04/01/2013 - "Correlation of nuclear morphometry of primary melanoma of the skin with clinicopathological parameters and expression of tumor suppressor proteins (p53 and p16(INK4a)) and bcl-2 oncoprotein."
08/19/2014 - "The RASSF (Ras association domain family) family of proteins consists of 10 members, many of which are tumor suppressor proteins that undergo loss of expression through promoter methylation in numerous types of cancers such as leukemia, melanoma, breast, prostate, neck, lung, brain, colorectal and kidney cancers. "
|1.||Cyclin-Dependent Kinases (cdk Proteins)
|2.||DNA-Directed RNA Polymerases (RNA Polymerase)
|4.||Proteins (Proteins, Gene)
|5.||Cyclin-Dependent Kinase Inhibitor p16
|6.||Tumor Suppressor Protein p14ARF (p14ARF)
|7.||Proto-Oncogene Proteins c-akt (Protein Kinase B)
|9.||Oncogene Proteins (Oncogene Protein)
|10.||Tumor Viral Antigens (Large T Antigen)